Long-term safety and clinical activity results from a phase Ib study of erlotinib plus atezolizumab in advanced NSCLC Meeting Abstract
| Authors: | Rudin, C.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V.; Sarkar, I.; Hernandez, G.; Foster, P.; Spahn, J.; O'Hear, C.; Gettinger, S. |
| Abstract Title: | Long-term safety and clinical activity results from a phase Ib study of erlotinib plus atezolizumab in advanced NSCLC |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | erlotinib; nsclc; atezolizumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S407 |
| Language: | English |
| ACCESSION: | WOS:000454014501077 |
| DOI: | 10.1016/j.jtho.2018.08.440 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: MA15.02 -- Source: Wos |
